![]() ![]() It is recommended to wait 6 months after completing the primary series or COVID-19 infection before receiving a booster dose.Ī booster dose is recommended for children 5 to 11 years of age, who have a health condition that increases their risk of severe illness from COVID-19. Children ages 6 to 11 are eligible to receive a booster dose with the pediatric Pfizer or Moderna COVID-19 vaccine. This will ensure the parent/guardian understands the risks of an earlier second dose as a longer time period between doses provides a stronger immune response.Ĭhildren 5 years of age are only eligible to receive a booster dose with the pediatric Pfizer COVID-19 vaccine. Parents/guardians who want their child to receive their second dose sooner (after 21 days for Pfizer or after 28 days for Moderna but before eight weeks for either vaccine) should discuss the risks and benefits with their immunizer or health care provider before vaccination. The recommended time between first and second doses for most children is eight weeks. Children must be five years old at the time of their immunization appointment. There are Moderna and Pfizer vaccines authorized for children 5-11 years old. Vaccine Eligibility for Children aged 5 to 11Ĭhildren in this age group are eligible to receive a primary COVID-19 vaccine series and a first booster dose. Parents/guardians who want their child to receive their next dose sooner (before eight weeks) should discuss the risks and benefits with their immunizer or health care provider before vaccination, to ensure the parent/guardian understands the risks of an earlier second dose.Ī longer time period between doses provides a stronger immune response.įor more information on the National Advisory Committee on Immunization (NACI) recommendations, please go to the Canadian Immunization Guide. It is recommended to start and finish the primary series with the same product if available. The interval between doses for most children is eight weeks. Pfizer: The primary series consists of 3 doses.The interval between the first and second dose for most children is eight weeks. ![]() ![]() Moderna: The primary series consists of 2 doses.There are two products authorized for children 6 months to 4 years: Booster doses are not available for this age group at this time.Ĭhildren must be at least six months of age at the time of their immunization appointment. A primary series consists of two or three doses depending on the vaccine product. Vaccine Eligibility for Children aged 6 months to 4 yearsĪll children in this age group are eligible to receive a primary COVID-19 vaccine series. Manitoba COVID-19 Vaccine Certificate, Canadian Proof of Vaccination Credential and Immunization records.Immunization after a COVID-19 infection.Vaccine Eligibility for Infants, Children, Youth and Adults who are Moderately to Severely Immunocompromised.Vaccine Eligibility for Youth and Adults aged 12 and Older.Vaccine Eligibility for Children aged 5 to 11.Vaccine Eligibility for Children aged 6 months to 4 years.You can make your vaccine appointment at some sites online or by calling 1-84. Use the Vaccine Finder to find a convenient location. The vaccine is also available from medical clinics, pharmacies and other locations. Vaccines are the best defense against the virus and individuals are encouraged to get vaccinated as soon as they are eligible, and ensure they receive all the doses recommended for the best protection. If you are wanting to receive a dose of the COVID-19 vaccine sooner than the fall, please speak to your health care provider to discuss further as getting a dose now would impact when you can get the updated formulation.Īll people in Manitoba aged 6 months and older are eligible for COVID-19 vaccination. Individuals vaccinated with the updated formulation are expected to benefit from a better immune response against XBB and its new variants, compared to current vaccines.īeginning in the fall of 2023 for those previously vaccinated against COVID-19, Health Canada recommends a dose of the new formulation of COVID-19 vaccine for individuals in the authorized age groups if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later). An updated formulation of the COVID-19 vaccine targeting the XBB variant is awaiting approval from Health Canada. Manitoba currently has bivalent Pfizer and Moderna vaccines for both primary series and boosters. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |